{
    "clinical_study": {
        "@rank": "26926", 
        "acronym": "AAMPTC", 
        "arm_group": [
            {
                "arm_group_label": "isotretinoin", 
                "arm_group_type": "Experimental", 
                "description": "Retinal nerve fibre layer measurement in patients under isotretinoin treatment"
            }, 
            {
                "arm_group_label": "lymecycline", 
                "arm_group_type": "Active Comparator", 
                "description": "Retinal nerve fibre layer measurement in patients under lymecycline treatment"
            }, 
            {
                "arm_group_label": "minocycline", 
                "arm_group_type": "Active Comparator", 
                "description": "Retinal nerve fibre layer measurement in patients under minocycline treatment"
            }, 
            {
                "arm_group_label": "doxycycline", 
                "arm_group_type": "Active Comparator", 
                "description": "Retinal nerve fibre layer measurement in patients under doxycycline treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "The exact incidence of optic disc swelling and idiopathic intracranial hypertension in\n      patients using antiacne medication is not known so far. The investigators hypothesize that\n      swelling of retinal nerve fibre layer measured by optical coherence tomography is more\n      frequent then assumed so far."
        }, 
        "brief_title": "Antiacne Medications Pseudotumor Cerebri", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Optic Disc Swelling", 
        "condition_browse": {
            "mesh_term": [
                "Edema", 
                "Hypertension", 
                "Papilledema", 
                "Pseudotumor Cerebri", 
                "Intracranial Hypertension"
            ]
        }, 
        "detailed_description": {
            "textblock": "Measurement of retinal nerve fibre layer using optical coherence tomography over a period of\n      6 to 9 months depending on exact antiacne medication."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Antiacne medication treatment indicated by dermatologist\n\n          -  age > 18 years\n\n          -  contraception if indicated\n\n        Exclusion Criteria:\n\n        - age < 18 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "310", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02149615", 
            "org_study_id": "KEK-ZH 2013-0433 AAMPTC", 
            "secondary_id": "2013DR4066"
        }, 
        "intervention": {
            "arm_group_label": [
                "isotretinoin", 
                "lymecycline", 
                "minocycline", 
                "doxycycline"
            ], 
            "description": "Measurement of retinal nerve fibre layer thickness using optic coherence tomography.", 
            "intervention_name": "Retinal nerve fibre layer measurement", 
            "intervention_type": "Other", 
            "other_name": "effect of medication on optic nerve fibre layer"
        }, 
        "intervention_browse": {
            "mesh_term": "Isotretinoin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "idiopathic intracranial hypertension", 
            "optic disc swelling", 
            "antiacne medication", 
            "isotretinoin"
        ], 
        "lastchanged_date": "May 26, 2014", 
        "link": {
            "description": "Study register Switzerland", 
            "url": "http://www.kofam.ch"
        }, 
        "location": {
            "contact": {
                "email": "isabelle.meneau@usz.ch", 
                "last_name": "Isabelle Meneau"
            }, 
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich"
            }, 
            "investigator": {
                "last_name": "Gregor Jaggi, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "4", 
        "official_title": "Prospective Open-label Phase IV Trial to Investigate the Frequency of Optic Disc Swelling, Idiopathic Intracranial Hypertension and Dry Eye Symptoms Under Antiacne Medication Treatment", 
        "overall_contact": {
            "email": "gregor.jaggi@usz.ch", 
            "last_name": "Gregor Jaggi, MD", 
            "phone": "0041 44 255 49 00"
        }, 
        "overall_contact_backup": {
            "email": "isabelle@meneau@usz.ch", 
            "last_name": "Isabelle Meneau"
        }, 
        "overall_official": {
            "affiliation": "UniversityHospital, Zurich", 
            "last_name": "Klara Landau, Prof MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement of retinal nerve fibre layer using optical coherence tomography. Changes over 10 micrometers are considered to be clinically relevant.\nThe Term \"retinal nerve fibre layer\" describes an automated standardized optical coherence tomography measurement program measuring the sectorial thickness of the peripapillar retinal nerve fibre layer. There exists no other term for that.", 
            "measure": "Retinal nerve fibre layer", 
            "safety_issue": "No", 
            "time_frame": "9 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02149615"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Zurich", 
        "sponsors": {
            "collaborator": {
                "agency": "University Hospital, Z\u00fcrich", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}